To confirm the role of mTOR in Dex-exacerbated experimental colitis, acute experimental ulcerative colitis was induced and then treated with Dex or rapamycin (a specific mTOR signal inhibitor, Rapa) or Rapa combined treatment with Dex, to observe the changes in acute experimental colitis. The gene discussed is MTOR; the disease is ulcerative colitis.